We are live on ! Find out more
GHA

GW Henssler & Associates Portfolio holdings

AUM $2.25B
1-Year Est. Return 19.46%
This Fund
S&P 500
This Quarter Est. Return
+11.56%
1 Year Est. Return
+19.46%
3 Year Est. Return
+62.37%
5 Year Est. Return
+80.78%
10 Year Est. Return
+246.81%
AUM
$1.42B
AUM Growth
+$88.1M
Cap. Flow
-$41.6M
Cap. Flow %
-2.92%
Top 10 Hldgs %
30.65%
Holding
221
New
12
Increased
54
Reduced
66
Closed
6

Top Buys

Rank Stock Value
1
AMCR icon
Amcor
AMCR
+$18.2M
2
EMR icon
Emerson Electric
EMR
+$12.7M
3
GSK icon
GSK
GSK
+$4.62M
4
KO icon
Coca-Cola
KO
+$1.36M
5
AAPL icon
Apple
AAPL
+$1.11M

Sector Composition

Rank Sector Weight
1 Healthcare 18.65%
2 Consumer Staples 12.46%
3 Financials 11.72%
4 Energy 10.49%
5 Technology 8.61%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
BUFD icon
1
FT Vest Fund of Deep Buffer ETFs
BUFD
$1.92B
$73.6M 5.16%
3,739,329
+28,534
+0.8% +$561K
IWN icon
2
iShares Russell 2000 Value ETF
IWN
$14.3B
$63.4M 4.45%
457,126
-13,189
-3% -$1.86M
AAPL icon
3
Apple
AAPL
$4.97T
$49.4M 3.47%
380,138
+7,733
+2% +$1.11M
MPC icon
4
Marathon Petroleum
MPC
$90.1B
$44.9M 3.15%
385,665
-8,795
-2% -$1M
CVX icon
5
Chevron
CVX
$382B
$39.6M 2.78%
220,634
-2,819
-1% -$492K
NVS icon
6
Novartis
NVS
$302B
$38M 2.67%
418,688
+7,857
+2% +$662K
XOM icon
7
ExxonMobil
XOM
$650B
$35.7M 2.51%
324,012
-5,053
-2% -$541K
MSFT icon
8
Microsoft
MSFT
$2.9T
$34.3M 2.41%
142,934
+2,686
+2% +$645K
LMT icon
9
Lockheed Martin
LMT
$131B
$29.5M 2.07%
60,718
-199
-0.3% -$92.5K
ABBV icon
10
AbbVie
ABBV
$465B
$28.2M 1.98%
174,466
-983
-0.6% -$151K
PM icon
11
Philip Morris
PM
$309B
$27.7M 1.95%
273,798
+3,990
+1% +$377K
PFG icon
12
Principal Financial Group
PFG
$24.3B
$27.5M 1.93%
328,012
-2,982
-0.9% -$256K
ALL icon
13
Allstate
ALL
$70.6B
$26.3M 1.84%
193,695
+2,161
+1% +$283K
PSX icon
14
Phillips 66
PSX
$82.9B
$26.2M 1.84%
252,208
-2,054
-0.8% -$210K
AEP icon
15
American Electric Power
AEP
$70.4B
$25.5M 1.79%
268,740
+5,366
+2% +$488K
SO icon
16
Southern Company
SO
$108B
$25.5M 1.79%
356,520
+4,892
+1% +$327K
AMGN icon
17
Amgen
AMGN
$209B
$25.1M 1.77%
95,714
-149
-0.2% -$39.9K
ICE icon
18
Intercontinental Exchange
ICE
$87.2B
$24.9M 1.75%
242,861
+2,942
+1% +$293K
CVS icon
19
CVS Health
CVS
$135B
$24.3M 1.7%
260,473
+132
+0.1% +$12.7K
KR icon
20
Kroger
KR
$36.7B
$23.8M 1.67%
533,074
+2,051
+0.4% +$94.2K
TRV icon
21
Travelers Companies
TRV
$81.1B
$22.3M 1.57%
119,136
+88
+0.1% +$15.8K
PEP icon
22
PepsiCo
PEP
$196B
$21.5M 1.51%
119,092
-422
-0.4% -$75.3K
SRE icon
23
Sempra
SRE
$58.1B
$20.8M 1.46%
268,756
+2,526
+0.9% +$195K
MRK icon
24
Merck
MRK
$322B
$20.8M 1.46%
187,052
-1,879
-1% -$192K
CAH icon
25
Cardinal Health
CAH
$53.7B
$19.9M 1.4%
258,752
-3,607
-1% -$274K

Similar funds

GW Henssler & Associates's Q4 2022 Portfolio in Review

As of Q4 2022, GW Henssler & Associates held 221 positions worth $1.42B, up 6.6% from $1.34B the previous quarter. Its ten largest holdings account for 31% of the portfolio.

GW Henssler & Associates's Q4 2022 filing shows 12 new, 54 increased, 66 reduced and 6 closed positions. Its largest new stake was Emerson Electric: 140,832 shares worth $13.5M. The largest sale was Archer Daniels Midland, an estimated $15.1M.

By sector, the portfolio is most concentrated in Healthcare at 19% of assets, up from 17% a quarter earlier, followed by Consumer Staples and Financials.

  • GW Henssler & Associates's largest Q4 2022 buy was Emerson Electric: 140,832 shares worth $13.5M.
  • GW Henssler & Associates added most to Amcor in Q4 2022, an estimated $18.2M increase.
  • GW Henssler & Associates's biggest Q4 2022 reduction was Archer Daniels Midland, cutting an estimated $15.1M.
  • GW Henssler & Associates fully exited Nuveen Short-Term REIT ETF in Q4 2022, selling an estimated $12.4M.
  • GW Henssler & Associates's ten largest holdings make up 31% of its $1.42B portfolio in Q4 2022.
  • GW Henssler & Associates opened 12 new positions and closed 6 in Q4 2022.
  • GW Henssler & Associates's portfolio value rose 6.6% quarter-over-quarter to $1.42B.

Based on GW Henssler & Associates's 13F filing for Q4 2022, filed 3 Feb 2023.